chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Pain, Vertigo
Clinical narrative: chills; severe body aches; headache 24 hours later; headache and dizziness described as vertigo 48 hours and still continuing 5 days later: ongoing vertigo; dizziness; This is a spontaneous report from a non-contactable physician. An adult female patient received second dose of bnt162b2, intramuscularly in right arm on 20Jan2021 12:30 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previous received first dose of bnt162b2 for covid-19 immunization. Not pregnant at the time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced chills, severe body, headache 24 hours later, headache and dizziness described as vertigo 48 hours and still continuing 5 days later: ongoing vertigo all on 21Jan2021. Exactly 12 hours after second dose: chills, severe body aches, headache, 24 hours later: headache and dizziness described as vertigo 48 hours and still continuing 5 days later: ongoing vertigo. The outcome of events was not resolved. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment received for the adverse event. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. Not allergies to medications, food, or other products. Not known allergies. No other medical history.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival pain, Glossodynia, Inappropriate schedule of product administration, Neck pain, Swollen tongue
Clinical narrative: administration_date=22Jan2021, dose_number=2/administration_date=30Dec2020, dose_number=1; Swollen and tenderness in tongue; Swollen and tenderness in tongue; Tender gums; soreness on right side of neck under ear; This is a spontaneous report from a contactable other hcp (patient). A 40-year-old female patient received second dose of bnt162b2 (lot number: EL3246), intramuscularly at arm left on 22Jan2021 15:00 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (lot number: EH9899) intramuscularly at left arm on 30Dec2020 15:00 for covid-19 immunisation. Not Pregnant at the time of vaccination. The patient receive no other vaccines within 4 weeks prior to the COVID vaccine. No any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced swollen and tenderness in tongue. Tender gums and soreness on right side of neck under ear, from 24Jan2021 08:00 AM. The adverse event result in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event included Prednisone and Pepcid. The outcome of the events was recovering.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Developed rash on her arm at the site of vaccine administration 6 days after vaccination, has not had pain nor itching associated with the rash.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasopharyngitis, Sinus disorder
Clinical narrative: little bit of headache and colds; little bit of headache and colds; feels more like a sinus; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient).  A 79-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 11Jan2021 at single dose for COVID-19 immunisation.  Medical history included the patient only had one lung (ongoing).  The patient's concomitant medications were not reported. The patient got the vaccine on 11Jan2021, and would be back in Feb for the 2nd dose. The patient wanted to know if she would still need to take the 2nd dose even though she had symptoms and a little bit of headache and colds, it feels more like a sinus. The outcome was unknown.    Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: fast heart rate; dizziness; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was experiencing fast heart rate and dizziness after received bnt162b2 on unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cough, Throat tightness
Clinical narrative: Throat right and coughing a lot
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Headache, Pyrexia
Clinical narrative: headache; diarrhea; low-grade fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that: A female patient of an unspecified age receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on 21Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller has a doctor's appointment for blood work and asked if it's okay since she already took the 1st dose on the 21Jan2021. She had a headache, diarrhea, and low-grade fever after the 1st dose in Jan2021. The patient underwent lab test which included body temperature: with result low-grade Fever on Jan2021. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: no appetite; chills; cough; fatigue; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced chills, cough, fatigue, shortness of breath, no appetite on 02Jan2021. The events resulted in: Doctor or other healthcare professional office/clinic visit. Event treatment included antibody IgG. Covid was tested post vaccination in Jan2021 with unknown result. The outcome of the events was recovering.   Information on Lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: no appetite; chills; cough; fatigue; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced chills, cough, fatigue, shortness of breath, no appetite on 02Jan2021. The events resulted in: Doctor or other healthcare professional office/clinic visit. Event treatment included antibody IgG. Covid was tested post vaccination in Jan2021 with unknown result. The outcome of the events was recovering.   Information on Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Illness, SARS-CoV-2 test
Clinical narrative: sick; diarrhea; some chills and headaches and symptoms like covid; some chills and headaches and symptoms like covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) of an unspecified age reported she received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced sick, diarrhea, some chills and headaches and symptoms like covid on Jan2021. She tested negative for covid in Jan2021. But she had a second test and was still waiting for the result of that in Jan2021. The event outcome of sick was not recovered; outcome of other events was unknown.   Information on the lot/batch number has been requested.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue pruritus
Clinical narrative: Patient started feeling itching of the tongue 20 minutes after the injection. Stabilized, discharged to home.
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine, Blood creatinine increased, Renal disorder
Clinical narrative: creatinine went up; creatinine went up; This is a spontaneous report from a contactable consumer reporting for her mother from a Pfizer-sponsored program.  A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2) , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The reporter stated that, the patient had kidney problems. Her creatinine went up after taking the vaccine. She was asking if her mother should still take the 2nd dose of the vaccine? The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Pain
Clinical narrative: Headache and muscle aches and joint pain; Headache and muscle aches and joint pain; Headache and muscle aches and joint pain; I woke up feeling sore. But then, as the day progressed I started feeling more achy; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EL3247), via an unspecified route of administration on 22Jan2021 at single dose for covid-19 immunisation.  Medical history included none.  There were no concomitant medications.  After she took the 1st dose she had a headache and muscle aches and joint pain. The patient stated, " I received the vaccine about 24 hours ago. At this point, I am just wondering if I can take Ibuprofen to help with some of the symptoms that I am feeling. If I do take Ibuprofen, is that going to like impact the response of the how the vaccine is working? I woke up feeling sore. But then, as the day progressed I started feeling more achy. So, like more muscle ache and headache." The outcome of the events was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site inflammation
Clinical narrative: Covid Arm - red lesion around the injection site not very itchy.  Appeared 8 days after moderna first dose which is the day i am submitting this form.  Size 3" long
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hyperhidrosis, Palpitations
Clinical narrative: flushing; palpitations; diaphoresis; This is a spontaneous report from a contactable other HCP reported for self. This 30-year-old female non-pregnant patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via intramuscular on 23Dec2020 at 12:30 at single dose in right arm for COVID-19 immunization. The patient's medical history included asthma, environmental allergies, eczema, anxiety/depression. The patient's concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL FE 24) 1/20, bupropion hydrochloride (WELLBUTRIN XL), fluoxetine hydrochloride (PROZAC), rizatriptan, salbutamol (ALBUTEROL) inhaler, fluticasone propionate (FLONASE), levocetirizine dihydrochloride (XYZAL), betamethasone topical. The patient had none known allergies although possible rash with acetylsalicylic acid (ASPIRIN) in the past- other NSAIDs are fine. The patient experienced flushing/palpitations/diaphoresis about 5 minutes after she received the vaccine, but this resolved quickly and spontaneously.   Information on lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: mild arm soreness; This is a spontaneous report from a contactable physician (patient) via Pfizer sales representative. A male patient of an unspecified age received the first dose of bnt162b2 (Lot/batch number and Expiration date were not provided), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced mild arm soreness on an unspecified date (a day or two after vaccine). The outcome of event was recovered on unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: mild arm soreness for a day or two; low fever; fatigue; This is a spontaneous report from contactable Physician (patient) via Pfizer Sales Representative. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. He received the first dose on an unknown date for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the Pfizer COVID vaccine, had mild arm soreness for a day or two after both injections. After the second injection he felt low fever, fatigue for 2 days. He feels fine now. Events outcome was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, Pain, Swelling
Clinical narrative: Body ache; Redness; Swelling; hard time breathing/shortness of breath/Difficulty breathing; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported that a female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that her mother took the first dose of vaccine last Friday 22Jan2021, and was now experiencing side effects, she was having a hard time breathing, body aches, swelling and redness in Jan2021. Reporter also mentioned that the patient was having shortness of breath and she was having difficulty breathing. The consumer wanted to know how long the side effects were expected to last and if they can worsen as the days go on. Because the patient had it on Friday, and it's already been almost 48 hours. Reporter stated that she needs to get off the phone because she need to call her mother's doctor's office and have to call the EMS for her. Outcome of events was unknown.  Information on the lot/batch number has been requested.
Age: 0.33
Sex: F
Vaccine: PNC13
Symptoms: Genital rash, Rash
Clinical narrative: Lasting rash, on neck, torso and genitals.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This is a spontaneous report from a contactable consumer (patient) via the Pfizer-sponsored Program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date (reported as "Monday"), at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she took her 1st dose of vaccine on Monday (unknown date) and had a side effect which was pain at the injection site. The outcome of the event was unknown.  Information about the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Cough; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. On an unspecified date, 5 days after the vaccination, the patient had cough. The outcome of the event, cough, was unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Urinary tract infection
Clinical narrative: throat is a little sore; UTI; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 23Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated that her throat is a little sore and asking if that is normal. Also, the patient was running to the bathroom to pee because of UTI, and every time she has that, she needs to take antibiotics. The patient asked if it's okay for her to take antibiotics. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: Felt a bit dizzy and weak; Felt a bit dizzy and weak; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 19Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 23Jan2021, the patient had felt a bit dizzy and weak. The outcome of the events, 'dizzy' and 'weak', was unknown.  Information on the batch/lot number has been requested.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash, Rash pruritic
Clinical narrative: Minimal soreness in  arm; nothing more immediately after vaccination Day 5: rash on right leg below knee, no itchiness. Day 8: injection arm red very, very, itchy rash; also rash om left leg below knee, not itchy
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Somnolence
Clinical narrative: Headaches; Bad chills; Diarrhea; Extreme tiredness; Sleeping a lot; This is a spontaneous report from a non-contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date not reported), via an unspecified route of administration on unspecified date at a single dose, for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient's wife called in because her husband (the patient) was experiencing side effects like headaches, bad chills, diarrhea, extreme tiredness, and was sleeping a lot after the vaccine. She was asking how long the side effects last. The outcome of the events was not recovered.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is sore; This is a Spontaneous report from a Pfizer sponsored program via a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration on 23Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient's arm was sore on an unspecified date on Jan2021 and she was asking if they can take cold or warm to get rid of the sore. Outcome of the event was unknown.  information on the LOT/Batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nasopharyngitis
Clinical narrative: common colds symptoms; flu-like symptoms; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable healthcare professional (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 23Jan2021, the patient experienced flu-like symptoms. On 24Jan2021, the patient had common cold symptoms. She was asking if she can take the vaccine tomorrow or she have to wait. Outcome of the events was unknown. Information on the lot/batch number has been requested.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Syncope right after injection given. Of note, he has a history of fainting episodes with injections. BP 131/83, pulse 79. Laid on floor with legs elevated. Given water, juice, and crackers. Resolved.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain on the injection site; This is a spontaneous report from a Pfizer-sponsored program via a non-contactable female Consumer (patient). A female patient of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown.) via an unspecified route of administration on 23Jan2021 at SINGLE DOSE (first dose) for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications.  Patient was asking if it is okay to take ALEVE PM because there was pain on the injection site after she got the 1st vaccine during the morning on an unspecified date. Outcome of the event pain on the injection site was unknown.  No follow up attempts are possible. Information on lot/batch cannot be obtained. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Computerised tomogram, Fatigue
Clinical narrative: This is a spontaneous report from a contactable consumer (patient) from the Pfizer-sponsored program. A 78-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/lot number: EL3248, expiration date: Apr2021) via an unspecified route of administration in left arm on 24Jan2021 13:30 at single dose for COVID-19 immunization. Medical history included lupus from 26Feb2019 and ongoing, biopsy done/diagnosed 26Feb2019, known to be cutaneous, unknown if systemic lupus erythematosus (SLE)-not officially diagnosed as SLE yet but keep monitoring to see, patient sister has possibly compromised immune system with lupus; ongoing allergies, included ongoing allergies/reactions to insect stings, wasp stings-that was first reaction 8-9 years ago-carried EpiPen since then, dye in a contrast medium for CT scan in Sep2020; had serious surgery, 2 subsequent surgeries, couldn't remember anything within last couple of years, 1st surgery: fall or beginning of 2019; scheduled to have surgery to repair abdominal surgery as a result of all the other stuff, had to cancel it and reschedule for spring due to rash, rash diagnosed as lupus; compromised immune status; respiratory illness; genetic / chromosomal abnormalities; endocrine abnormalities (including diabetes) and obesity; overweight. No allergies/reactions to vaccines historically. Concomitant medications included ongoing hydroxychloroquine (Zydus Pharmaceuticals, Lot number: E003901, Expiry date: 31May2022, NDC: Unknown, UPC: 4181077301, repeatedly verified dispensed in standard amber/orange pharmacy bottle; but had manufacturer label on bottle-no NDC) for lupus. The patient previously used epinephrine (EPIPEN, reported as Epi-pen) first/only time 2020: maybe summer/fall/Sep2020 for anaphylactic reaction to yellow jacket sting. On 24Jan2021 around 2:30pm she had onset of extreme fatigue (just like kind of an overwhelming fatigue). She had not even discussed having the vaccine with her PCP and did not consider extreme fatigue to be serious or something she needed to contact the doctor about. She ended up getting home, eating something, going upstairs and going to sleep (went "straight to bed"). She slept really well. Outcome improved, she was better, ok. She wondered if this was an extreme reaction to the vaccine or was this normal because this was the first shot, she read that the second dose creates even more pronounced side effects. She was asking if that was a normal reaction and can she expect that after the second dose? No vaccines administered on same date of the Pfizer suspect. The adverse event did not result in Emergency Room or Physician Office, and patient was not hospitalized. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The outcome of the event was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Soreness on her upper shoulder; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was wondering why her mother did not experience any reaction after getting the first dose of COVID-19 vaccine today unlike her. After getting the COVID-19 vaccine on an unspecified date, the patient experienced a reaction which was soreness on her upper shoulder for a couple of days. The patient recovered from the event on an unspecified date.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Gingival bleeding, Mouth haemorrhage
Clinical narrative: Abnormal bleeding in mouth and gums. Should I be seen by someone for this adverse reaction?  Please contact asap. Thank you  Wm. Bisceglia
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a Pfizer Sponsored Program. A contactable male consumer of unspecified age reported that he received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 06Jan2021, for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date in Jan2021 the patient tested positive for COVID. He was supposed to come back on 27Jan2021 and was asking if it was possible to delay the second vaccine. Event outcome was unknown. Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: fever; chills; body aches; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 20Jan2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient got the 1st dose of Covid 19 Vaccine 20Jan2021 and got all the side effects, fever, chills and body aches on an unspecified date. The outcome of events was unknown.  Information on the Lot/Batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination failure
Clinical narrative: First dose was not effective; This is a spontaneous report from a contactable Health Care Professional.   A patient of an unspecified age and gender received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on an unspecified date, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. It was reported that the first dose was not effective.  The information on the lot number has been requested.; Sender's Comments: Based on the information provided, the drug ineffective cannot be excluded for vaccine BNT162B2 administration.
Age: 86.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Angiogram, Echocardiogram, Myocardial infarction, Tremor
Clinical narrative: Uncontrolled  full body tremors, picked up by ambulance about 7:30pm, 2/7/21, and taken to ER, admitted due to heart attack, angiogram done 2/8/21, echo  done 2/9/21, released 2/9/21
Age: 86.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Abdominal pain upper, Acute myocardial infarction, Catheterisation cardiac abnormal, Chest pain, Coronary artery stenosis
Clinical narrative: Uncontrolled  full body tremors, picked up by ambulance about 7:30pm, 2/7/21, and taken to ER, admitted due to heart attack, angiogram done 2/8/21, echo  done 2/9/21, released 2/9/21
Age: 86.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Echocardiogram normal, Tremor, Troponin, Troponin increased
Clinical narrative: Uncontrolled  full body tremors, picked up by ambulance about 7:30pm, 2/7/21, and taken to ER, admitted due to heart attack, angiogram done 2/8/21, echo  done 2/9/21, released 2/9/21
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Nasopharyngitis
Clinical narrative: This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (EL8982) via an unspecified route of administration on 21Jan2021 12:30 at single dose in left arm for COVID-19 immunisation. No additional vaccines administered on same date of Pfizer suspect. Medical history included COVID-19 virus from Jun2020 to an unknown date. There were no concomitant medications. The patient reported fever, joint pain and tiredness, experienced fever, cold and chills after the first dose, all on Jan2021. She was asking how long these symptoms usually persist. The patient received COVID shot last Thursday. Had chills, fever, ugly fever blisters, and fatigue. The patient asked how long does the fatigue stay in the system because she is really tired. She was tired since 22Jan2021. She had chills on the night of 22Jan2021. She is done with fever and chills, she is just tired. Had COVID-19 virus in Jun2020. Feel like she has it again. The temperature was 99 degrees, began on night of 22Jan2021. Fever blisters started on 23Jan2021 reported as are subsiding, but still present. She was still really tired. Woke up Saturday and thought she had COVID-19 virus all over again. The events did not require visit to AES, because she was ok. Event outcome of fever blisters was not recovered, while for others was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, Pyrexia
Clinical narrative: This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (EL8982) via an unspecified route of administration on 21Jan2021 12:30 at single dose in left arm for COVID-19 immunisation. No additional vaccines administered on same date of Pfizer suspect. Medical history included COVID-19 virus from Jun2020 to an unknown date. There were no concomitant medications. The patient reported fever, joint pain and tiredness, experienced fever, cold and chills after the first dose, all on Jan2021. She was asking how long these symptoms usually persist. The patient received COVID shot last Thursday. Had chills, fever, ugly fever blisters, and fatigue. The patient asked how long does the fatigue stay in the system because she is really tired. She was tired since 22Jan2021. She had chills on the night of 22Jan2021. She is done with fever and chills, she is just tired. Had COVID-19 virus in Jun2020. Feel like she has it again. The temperature was 99 degrees, began on night of 22Jan2021. Fever blisters started on 23Jan2021 reported as are subsiding, but still present. She was still really tired. Woke up Saturday and thought she had COVID-19 virus all over again. The events did not require visit to AES, because she was ok. Event outcome of fever blisters was not recovered, while for others was unknown.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a Pfizer-sponsored program, Pfizert. A contactable male consumer of unspecified age reported that he received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Jan2021, for COVID-19 immunization. Medical history and concomitant medications were not reported. On 07Jan2021 the patient tested positive with Covid-19. He had to receive the second BNT162B2 dose on 26Jan2021. Event outcome was unknown. Information on the lot/batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Migraine, Pyrexia
Clinical narrative: fever; migraines; Chills; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient (Weight: 150 lbs, Height: 5'10) received first dose bnt162b2 (Batch Number: EL3248, expiry date: Apr2021), via an unspecified route of administration on 22Jan2021 at single dose for covid-19 immunization. Medical history included ongoing migraines. The patient's concomitant medications were not reported. The patient experienced chills in Jan2021, fever on 23Jan2021, migraines in Jan2021. Developed low grade fever (100.8) and chills after receiving the first dose of the Covid-19 vaccine. First does giving 22Jan2021. Fever started late evening 23Jan2021. Developed migraine approximately 6 hours after the shot. The patient underwent lab tests and procedures which included body temperature: low grade fever (100.8) an unspecified date. The outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Pruritus, Tongue discomfort, Vaccination site induration
Clinical narrative: Itchiness on both arms, tongue strange feeling , pain on site of vaccine 30 minutes after vaccination. 7 days after vaccination, hardness on site of vaccine, redness,  very itchy.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Itchiness on both arms, tongue strange feeling , pain on site of vaccine 30 minutes after vaccination. 7 days after vaccination, hardness on site of vaccine, redness,  very itchy.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body aches; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the second dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The received first dose of BNT162B2 for COVID-19 immunization. The patient experienced body aches which began 12 hours after the second dose on an unspecified date and lasted for around 24 hours. The outcome of event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Pyrexia, SARS-CoV-2 test positive, Somnolence
Clinical narrative: COVID; COVID; This is a spontaneous report from a contactable consumer. An 87-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Jan2021 maybe about 11:30am at single dose for COVID-19 immunization. Medical history included ongoing lung disorder started maybe 10 years ago or more, ongoing eye disorder onset may have been about 1 year ago, Carpel tunnel surgery on Jan2021 which was done on both wrists, ongoing weight decreased about 2 years ago, patient had cancer and has had some problems; they were going to the health clinics at the time and she had a horrible cough; she thinks, but does not know, if they did a bronchoscopy; but she saw some doctors and a cancer specialist. The patient had unknown concomitant medications for Thyroid. The patient was diagnosed with COVID 23Jan2021 and hospitalized in response which is ongoing. She is scheduled to get the second dose of Pfizer COVID-19 Vaccine on 27Jan2021. The patient body temperature is usually about 97.5 or 97.6 degrees Fahrenheit; but on Saturday: 23Jan2021 her temperature was 101.5 degrees Fahrenheit. Patient had her son take her to the hospital where they did the COVID test and it was positive for COVID; so she was admitted to the hospital for this on 23Jan2021. She is hospitalized at the same hospital where she was administered the first dose of Pfizer COVID-19 Vaccine and the hospital staff were shocked that she had gotten one of their Pfizer COVID-19 Vaccines. The patient was at the hairdresser's on 22Jan2021 who said the patient did not look good then; that she really looked sick; but apparently the patient did not have any symptoms 22Jan2021. It was not until unknown time on 23Jan2021 that her temperature went up; patient feels like her reaction is to the fever; where she just wants to sleep all the time. Patient probably does not have any energy. Caller does not hear her coughing when she talks to the patient. Caller clarified that to her awareness the patient's potential exposure to COVID positive persons would have been through the grocery store; or the health plex gym where caller and the patient go together but the patient said the health plex gym machines are spaced out well and there are no known exposures to COVID positive persons. Outcome of events was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea, Pyrexia
Clinical narrative: Nausea woke me 10 hours after injection, followed shortly by 101 degree fever, muscle and joint aching. Fever lasted 38 hours, muscle joint soreness is less the 2nd day but still mildly present, nausea continues though finally able to eat a small bit of soup as of 48 hours post-injection.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Facial pain, Neck pain
Clinical narrative: chills; pain in her face and neck; pain in her face and neck; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient herself) reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose in left arm and second dose in right arm, both via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced chills, pain in her face and neck on an unspecified date. Outcome of events were unknown.   Information on the lot/batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Onset of fever 10 hours after vaccination, resolved by the 24 hour mark. Arm stiffness and lymph node swelling in the left armpit beginning 36 hours after vaccine.
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: a metallic taste in mouth; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received Covid vaccine on 22Jan2021 and had a metallic taste in mouth in Jan2021- wondering if that was normal. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Vaccination site pain
Clinical narrative: Sore arm near injection site and throughout arm; minor numbness in elbow and fingers; Sore arm near injection site and throughout arm; This is a spontaneous report from a contactable consumer reported for himself. A 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3247), via an unspecified route of administration in left arm on 25Jan2021 14:15 at first single dose for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. No allergies to medications, food, or other products. No other medical history. No other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore arm near injection site and throughout arm including minor numbness in elbow and fingers. Adverse event start date: 25Jan2021 04:30 PM. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: several years ago I lost my sense of smell. 6 days after receiving my first dose of covid 19 vaccine I noticed my sense of smell returned; This is a spontaneous report from a contactable consumer (patient). A 78-year-old patient of an unspecified gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. Medical history included lost of sense of smell several years ago. The patient's concomitant medications were not reported. The patient reported that several years ago, he/she lost his/her sense of smell. Six days after receiving the first dose of Covid 19 vaccine patient noticed that his/her sense of smell returned. Patient was thrilled. He/she was a healthy 78-year-old and wants to know if this a side effect of the vaccine or a coincidence. Outcome of the event was unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia, Nausea, Pain in extremity, Sitting disability
Clinical narrative: Severe Dizziness and Nausea lasting 8 hours.  Unable to sit or stand.  After 8 hours the symptom has lessened considerably.   Expected sore arm is not worrisome.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Condition aggravated, Erythema, Feeling abnormal, Pruritus
Clinical narrative: fever; felt terrible; His rash ran up and down his torso, arms and hips/rash got worse; His rash ran up and down his torso, arms and hips; It was red and angry and itchy; It was red and angry and itchy; This is a spontaneous report from a contactable consumer reporting for husband. A 71-year-old male patient received first dose of bnt162b2 (BNT162B2, batch/lot number EL0142), via an unspecified route of administration on 14Jan2021 at single dose on right arm for COVID-19 immunisation. Medical history included slight rash on his stomach, ongoing allergy to pain relievers and fever reducers. The patient's concomitant medications were not reported. The patient previously took ibuprofen (ADVIL), Tylenol, aspirin (acetylsalicylic acid) and was allergic. The patient had a slight rash on his stomach before he received his dose. However, on 16Jan2021 he had a fever of about 100F. On 16Jan2021, his rash ran up and down his torso, arms and hips. It was red and angry and itchy. He applied Benadryl, hydrocortisone cream and aloe. He had a regularly scheduled (Institution name) appt and was prescribed prednisone, but it caused nausea and night terrors, so he stopped it. His rash is getting better. His 2nd dose is scheduled for 04Feb2021. The fever stayed just under 100.0 but he kept it all day long and felt terrible on 16Jan2021. He has had a horrible rash on his upper torso and top of his legs. It was getting bad and they were putting everything they could on it. Cortisone 10 was used and they seem to have it in check. He had a (Institution name) appointment and his doctor gave him prednisone to help but this made him sick to stomach at day 2 or 3 and so he stopped that product. Now the rash is coming back and they are wondering if is this part of the vaccine side effects. Caller remarks they didn't know what caused the rash to get worse, the vaccine or something else. The first dose was on 14Jan2021. The caller confirmed the fever started on day 2 all day long but broke that night and the next day he felt much better. On day 2 the rash got worse and itching like crazy, he remarked he felt like he fell in fire ants. At this point the rash is ok but is starting to itch again, they are applying everything they can think of to treat it. When her husband say his physician assistant at the (Institution name) she gave him the prednisone but he was nauseous and said he can't deal with that. He wasn't sure if he would rather itch or throw up so he did not complete the prednisone. Caller clarified the product is actually called Methylprednisone by Greenstone LLC. Therapeutic measures were taken as a result of it was red and angry and itchy (erythema), it was red and angry and itchy (pruritus) , his rash ran up and down his torso, arms and hips (rash). The outcome of fever, felt terrible was resolved on 16Jan2021, of other events was not resolved.